FDA Inspection
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby LaboratoriesThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories – FDA Inspection, Mar 20, 2026
Record Details
This FDA Inspection record concerns The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories, with an inspection on March 20, 2026, issued by the New Orleans District Office, covering human drugs.
- Inspection Date
- March 20, 2026
- Product Type
- Human Drugs
View Company Profile
ID · e8a9187e-816e-4fac-96ac-e1cc25b231f1
Inspection Facts
- Inspection number
- 1293976
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- FDCA 582(b)(4)Systems in place to comply with verification requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- FDA Inspection 994258 - 2016-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.